| [1] |
Lynch HT,Smyrk T. Hereditary nonpolyposis colorectal cancer(Lynch syndrome). Cancer, 1996, 78(6): 1149-1167.
|
| [2] |
Watne AL.Colon Polyps.J Surg Oncol, 1979, 66(3): 207-214.
|
| [3] |
Marra G,Boland CR.Hereditary nonpolyposis cancer：the syndrome, the gene, and historical perspectives.J Nat Cancer Inst, 1995, 87(15): 1114-1123.
|
| [4] |
Lynch HT,Smyrk T,Lynch JF.Molecular genetics and clinical-pathology features of hereditary nonpolyposis cancer.Oncology, 1998, 55(2): 103-108.
|
| [5] |
Lynch HT,Lynch PM,Lanspac SJ, et al.Review of the Lynch syndrome：history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.ClinGenet, 2009, 76: 1-18.
|
| [6] |
Vasen HFA,Moslein G,Alonso A, et al.Guidelines for the clinical management of Lynch syndrome(hereditary non-polyposis cancer). J Med Genet, 2007, 44: 353-362.
|
| [7] |
Laghi L,Bianchi P,Roncalli M, et al.Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer(Lynch syndrome)and microsatellite instability.J Natl Cancer Inst, 2004, 96: 1402-1403.
|
| [8] |
Hampel H,Frankel WL,Martin E, et al.Feasibility of screening for Lynch syndrome among patients with colorectal cancer.J Clin Oncol, 2008, 26: 5783-5788.
|
| [9] |
Boland CR,Lynch HT.The history of Lynch syndrome.Fam Cancer 2013, 12: 145-157.
|
| [10] |
Steinke V,Engel C,Büttner R,Schackert HK,Schmiegel WH,Propping P. Hereditary nonpolyposis colorectal cancer(HNPCC)/Lynch syndrome.Dtsch Arztebl Int 2013, 110: 32-38.
|
| [11] |
Stoffel E,Mukherjee B,Raymond VM, et al.Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.Gastroenterology, 2009, 137: 1621-1627.
|
| [12] |
Thibodeau SN,Bren G,Schaid D. Microsatellite instability in cancer of the proximal colon.Science, 1993, 260: 816-819.
|
| [13] |
张渊智,盛剑秋,李世荣, 等. 中国部分地区结直肠癌遗传易感性与遗传性非息肉病性结直肠癌流行状况分析. 中华医学杂志, 2005, 85: 2995-3000.
|
| [14] |
Rustgi AK.Thegenetics of hereditary coloncancer.Genes Dev, 2007, 21: 2525-2538.
|
| [15] |
Palomaki GE,Mc Clain MR,Melillo S,Hampel HL,Thibodeau SN.EGAPP supplementary evidence review：DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.Genet Med, 2009, 11: 42-65.
|
| [16] |
Pai R,Wilcox R,Hart J. Molecular gastrointestinal, liver, and pancreatic pathology.Cell and tissue based molecular pathology, 2009: 269-293.
|
| [17] |
Pino MS,Chung DC.Application of molecular diagnostics for the detection of Lynch syndrome.Expert Rev Mol Diagn, 2010, 10: 651-665.
|
| [18] |
Sinicrope FA,Sargent DJ.Molecular pathways：microsatellite instability in colorectal cancer：prognostic, predictive, and therapeutic implications.Clin Cancer Res, 2012, 18: 1506-1512.
|
| [19] |
李智,夏庆欣,庄兢, 等. 我国汉族人群"遗传性非息肉性大肠癌"临床判别标准的探讨. 中国现代医学杂志, 2004, 14(22): 71-73.
|
| [20] |
Lagerstedt Robinson K,Liu T,Vandrovcova J, et al.Lynch syndrome(hereditary nonpolyposis colorectal cancer)diagnostics.J Natl Cancer Inst, 2007, 99(4): 291-299.
|
| [21] |
Walsh MD,Cummings MC,Buchanan DD, et al.Molecular, pathologic, and clinical features of early-onset endometrial cancer：identifying presumptive Lynch syndrome patients.Clin Cancer Res, 2008, 14(6): 1692-1700.
|
| [22] |
Herraiz M,Munoz-Navas M. Recognition and management of hereditary colorectal cancer syndromes.Rev Esp Enferm Dig, 2009, 101(2): 125-132.
|
| [23] |
Moreira L,Balaguer F,Lindor N, et al.Identification of Lynch syndrome among patients with colorectal cancer.JAMA, 2012, 308: 1555-1565.
|
| [24] |
Julie C,Tresallet C,Brouqet A, et al.Indentification in daily practice of patients with lynch syndrome(Hereditary nonpolyposis colorectal cancer)：revised bethesda guidelines-based approach versus molecular screening.Am J Gastroenterol, 2008, 103(11): 2825-2835.
|
| [25] |
袁瑛,张苏展,郑树. 中国人遗传性大肠癌筛检标准的实施方案. 中华肿瘤杂志, 2004, 26(12): 191-192.
|
| [26] |
Stupart DA,Goldberg PA,Algar U, et al.Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation.Colorectal Dis, 2009, 11(2): 126-130.
|
| [27] |
Kalady MF.Surgical management of hereditary nonpolyposis colorectal cancer.Adv Surg, 2011, 45: 265-274.
|
| [28] |
Evaluation of Genomic Applications in Practice and Prevention(EGAPP)Working Group.Recommendations from the EGAPP Working Group：genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.Genet Med, 2009, 11(1): 35-41.
|
| [29] |
Natarajan N,Watson P,Silva-Lopez E, et al.Comparison of extended colectomy and limited resection in patients with Lynch syndrome.Dis Colon Rectum, 2010, 53: 77-82.
|
| [30] |
Steinbach G,Lynch P,Phillips R, et al.The effect of celecoxib：acyclo oxygenase-2 inhibitor in familial adenomatous polyposis.N Engl J Med, 2000, 342(26): 1946-1952.
|
| [31] |
John Burn,Timothy Bishop,Mecklin Jukka-Pekka, et al.Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.N Engl J Med, 2008, 359: 2567-2578.
|